RICHARD A. MEIER - 03 Jun 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
03 Jun 2024
Net transactions value
-$50.91
Form type
4
Filing time
04 Jun 2024, 19:28:12 UTC
Previous filing
23 May 2024
Next filing
22 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $416,460 +6,600 +5.5% $63.10 126,227 03 Jun 2024 Direct
transaction BMRN Common Stock Tax liability $416,511 -5,451 -4.3% $76.41 120,776 03 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Options Exercise $0 -6,600 -100% $0.000000* 0 03 Jun 2024 Common Stock 6,600 $63.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transactions from this specific stock option grant.